Technical Analysis for JNCE - Jounce Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical JNCE trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Bearish Engulfing | Bearish | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| 20 DMA Resistance | Bearish | -6.63% | |
| Pocket Pivot | Bullish Swing Setup | -6.63% | |
| Doji - Bearish? | Reversal | -6.63% | |
| Earnings Movers | Other | -6.63% | |
| New Uptrend | Bullish | -0.27% | |
| Oversold Stochastic | Weakness | -0.27% | |
| New Downtrend | Bearish | 0.27% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 1.5x Volume Pace | about 19 hours ago | |
| Fell Below 10 DMA | about 19 hours ago | |
| 10 DMA Support | about 19 hours ago | |
| 20 DMA Resistance | about 19 hours ago | |
| Down 5% | about 19 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2021
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Immunology Solid Tumors Immune System Natural Sciences Immunotherapy Monoclonal Antibodies Monoclonal Antibody
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Immunology Solid Tumors Immune System Natural Sciences Immunotherapy Monoclonal Antibodies Monoclonal Antibody
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.08 |
| 52 Week Low | 2.85 |
| Average Volume | 486,112 |
| 200-Day Moving Average | 7.49 |
| 50-Day Moving Average | 9.70 |
| 20-Day Moving Average | 11.85 |
| 10-Day Moving Average | 11.23 |
| Average True Range | 0.96 |
| ADX | 32.15 |
| +DI | 23.91 |
| -DI | 17.72 |
| Chandelier Exit (Long, 3 ATRs ) | 11.20 |
| Chandelier Exit (Short, 3 ATRs ) | 12.66 |
| Upper Bollinger Band | 13.44 |
| Lower Bollinger Band | 10.26 |
| Percent B (%b) | 0.23 |
| BandWidth | 26.86 |
| MACD Line | 0.26 |
| MACD Signal Line | 0.51 |
| MACD Histogram | -0.2538 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 12.89 | ||||
| Resistance 3 (R3) | 13.06 | 12.61 | 12.57 | ||
| Resistance 2 (R2) | 12.61 | 12.12 | 12.52 | 12.46 | |
| Resistance 1 (R1) | 11.79 | 11.82 | 11.57 | 11.62 | 12.36 |
| Pivot Point | 11.34 | 11.34 | 11.22 | 11.25 | 11.34 |
| Support 1 (S1) | 10.52 | 10.85 | 10.30 | 10.35 | 9.60 |
| Support 2 (S2) | 10.07 | 10.55 | 9.98 | 9.50 | |
| Support 3 (S3) | 9.25 | 10.07 | 9.39 | ||
| Support 4 (S4) | 9.08 |
